Health Industry

Latest KFF Health News Stories

Rep. Chris Collins’ Australian Stock Bet Looks Bleaker

KFF Health News Original

Innate Immunotherapeutics, the Australian biotech firm whose largest shareholder is Buffalo, N.Y.-area congressman Chris Collins, said it expects to close after its multiple sclerosis drug failed in trials.

St. Kitts Launches Probe Of Herpes Vaccine Tests On U.S. Patients

KFF Health News Original

After a Kaiser Health News report on an offshore herpes vaccine trial that skirted FDA regulations, St. Kitts and Nevis officials claim they had no knowledge of the testing. An investigation is underway.

Facebook Live: The Prescription Drug Pricing Pipeline

KFF Health News Original

In this Facebook Live, KHN’s Julie Appleby talks with Stephanie Stapleton and answers readers’ questions about the prescription drug pricing pipeline and the industry stakeholders who have a role in what you pay.

Mayo Pain Expert: Holistic Approach Helps Patients Ditch Opioids

KFF Health News Original

Painkillers were never designed to be used over the long term, says the head of the Mayo Clinic’s pain rehabilitation center. Instead, patients should try other approaches, including relaxation therapies. But getting insurers to cover them might take coaxing.

Podcast: ‘What The Health?’ Back To Health Crunch Come September

KFF Health News Original

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Margot Sanger-Katz of The New York Times discuss the continuing efforts in Congress to “repeal and replace” the Affordable Care Act, upcoming open enrollment for individual insurance and Congress’ long health care to-do list for September.

Podcast: ‘What The Health?’ Why Is It So Difficult To Control Drug Prices?

KFF Health News Original

In this episode of “What the Health?” Mary Agnes Carey of Kaiser Health News, Sarah Karlin-Smith of Politico, Margot Sanger-Katz of The New York Times and Julie Appleby of Kaiser Health News discuss the recent extension of cost-sharing subsidies for millions of low-income beneficiaries on the Affordable Care Act’s marketplaces and the state of play on Capitol Hill and in the states concerning initiatives to lower prescription drug costs.

Podcast: ‘What The Health?’ No Vacation For Insurers

KFF Health News Original

In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Sarah Kliff of Vox.com, and Margot Sanger-Katz of The New York Times discuss the state of the individual health insurance markets in the wake of the failure (for now) of Congress’s efforts to repeal and replace the Affordable Care Act.